Table 2.
Mean levels and prevalence of metabolic syndrome by gender and geographic location.
| Component cutpoint (must meet ≥1 of the cutpoints per component) | Prevalence | Mean (SD) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buffalo | Spokane | Buffalo | Spokane | ||||||||||||||
| Metabolic syndrome component | Men | Women | Overall | Men | Women | Overall | Men | Women | Men | Women | |||||||
| N | %* | N | %* | N | %* | N | %* | N | %* | N | %* | (N = 304) | (N = 106) | (N = 121) | (N = 9) | ||
| Abdominal obesity | 113 | 37.2 | 18 | 17.0 | 131 | 32.0 | 48 | 39.7 | 5 | 55.6 | 53 | 40.8 | |||||
| Waist circumference, cm | ≥102 Men, ≥88 Women | 99.3 (11.4) | 79.9 (11.5) | 100.3 (10.8) | 87.5 (9.9) | ||||||||||||
| Elevated triglycerides | 117 | 38.5 | 9 | 8.5 | 126 | 30.7 | 52 | 43.0 | 3 | 33.3 | 55 | 42.3 | |||||
| Triglycerides, mg/dL | ≥150 | 113 | 37.2 | 9 | 8.5 | 122 | 28.6 | 53 | 42.7 | 3 | 30.0 | 56 | 41.8 | 153.8 (127.4) | 88.4 (130.0) | 157.6 (102.7) | 165.3 (150.6) |
| Self-reported fibrates or nicotinic acid medication, % | Yes | 6 | 2.0 | 1 | 0.9 | 7 | 1.7 | 5 | 4.1 | 0 | 0.0 | 5 | 3.8 | ||||
| Reduced HDL cholesterol | 143 | 47.0 | 28 | 26.4 | 171 | 41.7 | 53 | 43.8 | 2 | 22.2 | 55 | 42.3 | |||||
| HDL cholesterol, mg/dL | <40 Men, <50 Women | 142 | 46.7 | 28 | 24.8 | 170 | 40.0 | 54 | 43.5 | 2 | 20.0 | 56 | 41.8 | 42.2 (12.0) | 58.3 (15.7) | 42.6 (12.4) | 56.0 (16.1) |
| Self-reported fibrates or nicotinic acid medication, % | Yes | 6 | 2.0 | 1 | 0.9 | 7 | 1.7 | 5 | 4.1 | 0 | 0.0 | 5 | 3.8 | ||||
| Glucose intolerance | 83 | 27.3 | 12 | 11.3 | 95 | 23.2 | 46 | 38.0 | 3 | 33.3 | 49 | 37.7 | |||||
| Fasting glucose, mg/dL | ≥100 | 81 | 26.6 | 11 | 10.4 | 92 | 21.9 | 48 | 38.7 | 3 | 30.0 | 51 | 38.1 | 94.7 (14.0) | 86.4 (8.4) | 98.9 (10.7) | 93.4 (10.3) |
| Self-reported diabetes medication, % | Yes | 7 | 2.3 | 1 | 0.9 | 8 | 2.0 | 4 | 3.3 | 0 | 0.0 | 4 | 3.1 | ||||
| Hypertension | 129 | 42.4 | 27 | 25.5 | 156 | 38.1 | 55 | 45.5 | 2 | 22.2 | 57 | 43.9 | |||||
| Systolic blood pressure, mmHg | ≥130 | 69 | 22.7 | 18 | 17.0 | 87 | 20.9 | 37 | 29.8 | 3 | 30.0 | 40 | 29.9 | 122.2 (11.3) | 116.7 (13.3) | 125.0 (10.3) | 121.8 (10.1) |
| Diastolic blood pressure, mmHg | ≥85 | 79 | 26.0 | 17 | 16.0 | 96 | 23.3 | 35 | 28.2 | 0 | 0.0 | 35 | 26.1 | 78.7 (10.2) | 74.6 (9.6) | 81.1 (8.5) | 78.9 (4.7) |
| Self-reported hypertension with antihypertensive medication, % | Yes | 45 | 14.8 | 7 | 6.6 | 52 | 12.7 | 17 | 14.0 | 0 | 0.0 | 17 | 13.0 | ||||
| Number of components | 1.9 (1.4) | 0.9 (1.1) | 2.1 (1.4) | 1.7 (1.9) | |||||||||||||
| 0 | 54 | 17.8 | 53 | 50.0 | 107 | 26.1 | 14 | 11.6 | 4 | 44.4 | 18 | 13.9 | |||||
| 1 | 75 | 24.7 | 25 | 23.6 | 100 | 24.4 | 32 | 26.5 | 1 | 11.1 | 33 | 25.4 | |||||
| 2 | 79 | 26.0 | 19 | 17.9 | 98 | 23.9 | 30 | 24.8 | 1 | 11.1 | 31 | 23.9 | |||||
| 3 | 48 | 15.8 | 6 | 5.7 | 54 | 13.2 | 22 | 18.2 | 1 | 11.1 | 23 | 17.7 | |||||
| 4 | 32 | 10.5 | 2 | 1.9 | 34 | 8.3 | 19 | 15.7 | 1 | 11.1 | 20 | 15.4 | |||||
| 5 | 16 | 5.3 | 1 | 0.9 | 17 | 4.2 | 4 | 3.3 | 1 | 11.1 | 5 | 3.9 | |||||
| Prevalence (≥3) | 96 | 31.6 | 9 | 8.5 | 105 | 25.6 | 45 | 37.2 | 3 | 33.3 | 48 | 36.9 | |||||